Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Alzheimer's Association International Conference (AAIC) 2024 was held in Philadelphia, PA, and online, from 28 July - 01 August. This meeting brought together dementia researchers to discuss the latest advances.

AAIC 2024

28 Jul–01 August 2024 | Philadelphia, PA

AAIC 2024

28 Jul–01 August 2024 | Philadelphia, PA
The Alzheimer's Association International Conference (AAIC) 2024 was held in Philadelphia, PA, and online, from 28 July - 01 August. This meeting brought together dementia researchers to discuss the latest advances.
Comparing different assays for detecting AD plasma biomarkers 1:31
Comparing different assays for detecting AD plasma biomarkers
Gemma Salvadó • 20 Aug 2024
The association between infectious diseases and dementia 6:13
The association between infectious diseases and dementia
Cornelia van Duijn • 26 Jul 2024
Using plasma ptau217 to select cognitively unimpaired participants for AD prevention trials 4:34
Using plasma ptau217 to select cognitively unimpaired participants for AD prevention trials
Gemma Salvadó • 20 Aug 2024
Comparing plasma ptau217 with CSF biomarkers for predicting tau PET status 1:02
Comparing plasma ptau217 with CSF biomarkers for predicting tau PET status
Gemma Salvadó • 20 Aug 2024
Using blood testing to improve the accuracy of AD diagnosis in primary and secondary care settings 3:32
Using blood testing to improve the accuracy of AD diagnosis in primary and secondary care settings
Suzanne Schindler • 13 Aug 2024
The accuracy of plasma tau217 biomarkers in detecting AD pathology 2:27
The accuracy of plasma tau217 biomarkers in detecting AD pathology
Gemma Salvadó • 20 Aug 2024
Looking back over the first year of lecanemab use in AD: benefits and challenges 4:19
Looking back over the first year of lecanemab use in AD: benefits and challenges
Suzanne Schindler • 13 Aug 2024
A head-to-head comparison of AD blood tests reveals the value of ptau217 7:08
A head-to-head comparison of AD blood tests reveals the value of ptau217
Suzanne Schindler • 13 Aug 2024
The evolution of biomarker testing in AD: CSF, blood, and PET 5:25
The evolution of biomarker testing in AD: CSF, blood, and PET
Suzanne Schindler • 13 Aug 2024
The minimum acceptable performance of blood biomarker tests for diagnosing AD 5:12
The minimum acceptable performance of blood biomarker tests for diagnosing AD
Suzanne Schindler • 13 Aug 2024
The clinical use of tau-PET: its value and limitations 1:50
The clinical use of tau-PET: its value and limitations
Cécile Tissot • 13 Aug 2024
Highlights from AAIC 2024: tau-PET harmonization and the DIAN-TU trial 2:09
Highlights from AAIC 2024: tau-PET harmonization and the DIAN-TU trial
Cécile Tissot • 13 Aug 2024
Improving tau-PET harmonization: the HEAD study 5:57
Improving tau-PET harmonization: the HEAD study
Cécile Tissot • 13 Aug 2024
The spread of oligomeric tau through synapses in Alzheimer’s disease 8:11
The spread of oligomeric tau through synapses in Alzheimer’s disease
Tara Spires-Jones • 5 Aug 2024
The content of VJDementia is intended for healthcare professionals